DrugDashboards

Sumatriptan Succinate and Naproxen Sodium

sumatriptan succinate and naproxen sodium · SUMATRIPTAN SUCCINATE 85 mg/1; NAPROXEN SODIUM 500 mg/1 · Tablet · Oral · Currax Pharmaceuticals LLC dba Cypress, Hawthorn, Macoven

NDC 44183-0850-09 · 9 TABLET in 1 BOTTLE · NDA AUTHORIZED GENERIC · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has fallen 35% in a year, to $17.87 per unit — and generics that get this cheap tend to get abandoned rather than defended.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Federal ceiling (Big4)$5.71per unitCurrax Pharmaceuticals LLC · Jan 1, 2026
  • Medicaid generic ceiling (FUL)$44.53per TABweighted avg manufacturer price $25.4441 · Nov 1, 2023

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$25.00$50.00$75.00Jul 2018Aug 2023$17.87
47 price points · per · last surveyed Invalid Date · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Medicaid spend (2022)

$2,724
11 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA021926
TE code
AB
Approval date
Apr 15, 2008
Patents / exclusivity
4 patents, 0 exclusivities
TypeNumber / codeExpires
patent7332183*PEDApr 2, 2026
patent7332183*PEDApr 2, 2026
patent7332183Oct 2, 2025
patent7332183Oct 2, 2025

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of sumatriptan succinate and naproxen sodium (Tablet)

LabelerStrengthFirst seenLast seen
Currax Pharmaceuticals LLC dba Cypress, Hawthorn, MacovenSUMATRIPTAN SUCCINATE 85 mg/1; NAPROXEN SODIUM 500 mg/1Aug 26, 2026Sep 2, 2026
Currax Pharmaceuticals LLC dba Cypress, Hawthorn, MacovenSUMATRIPTAN SUCCINATE 500 mg/1; NAPROXEN SODIUM 85 mg/1Jul 22, 2026Aug 19, 2026
Currax Pharmaceuticals LLC dba Cypress, Hawthorn, MacovenNAPROXEN SODIUM 500 mg/1; SUMATRIPTAN SUCCINATE 85 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sumatriptan Succinate and Naproxen Sodium — NDC 44183-0850-09," retrieved September 3, 2026, https://drugdashboards.com/drug/44183085009.

Free to cite with attribution — see how the data is put together.